Your browser doesn't support javascript.
loading
Western Blot of Tau Protein from Mouse Brains Extracts: How to Avoid Signal Artifacts.
Fereydouni-Forouzandeh, Parissa; Canet, Geoffrey; Diego-Diàz, Sofia; Rocaboy, Emma; Petry, Serena; Whittington, Robert A; Planel, Emmanuel.
Afiliación
  • Fereydouni-Forouzandeh P; Université Laval, Faculté de Médecine, Département de Psychiatrie et Neurosciences, Quebec, QC, Canada.
  • Canet G; Université Laval, Faculté de Médecine, Département de Psychiatrie et Neurosciences, Quebec, QC, Canada.
  • Diego-Diàz S; Centre de Recherche du CHU de Québec - Université Laval, Axe Neurosciences, Quebec, QC, Canada.
  • Rocaboy E; Université Laval, Faculté de Médecine, Département de Psychiatrie et Neurosciences, Quebec, QC, Canada.
  • Petry S; Centre de Recherche du CHU de Québec - Université Laval, Axe Neurosciences, Quebec, QC, Canada.
  • Whittington RA; Université Laval, Faculté de Médecine, Département de Psychiatrie et Neurosciences, Quebec, QC, Canada.
  • Planel E; Centre de Recherche du CHU de Québec - Université Laval, Axe Neurosciences, Quebec, QC, Canada.
Methods Mol Biol ; 2754: 309-321, 2024.
Article en En | MEDLINE | ID: mdl-38512673
ABSTRACT
Tau is a microtubule-associated protein enriched in the axonal compartment. Its most well-known function is to bind and stabilize microtubules. In Alzheimer's disease and other neurodegenerative diseases known as tauopathies, tau undergoes several abnormal post-translational modifications including hyperphosphorylation, conformational changes, oligomerization, and aggregation. Numerous mouse models of tauopathies have been developed, and Western blotting remains an invaluable tool in studying tau protein physiological and pathological changes in these models. However, many of the antibodies that have been developed to analyze tau post-translational modifications are mouse monoclonal, which are at risk of producing artifactual signals in Western blotting procedures. This risk does not arise due to their lack of specificity, but rather because the secondary antibodies used to detect them will also react with the heavy chain of endogenous mouse immunoglobulins (Igs), leading to a non-specific signal at the same molecular weight as tau protein (around 50 kDa). Here, we present the use of anti-light-chain secondary antibodies as a simple and efficient technique to prevent non-specific Ig signals around 50 kDa. We demonstrate the efficacy of this method by either eliminating or identifying artifactual signals when using monoclonal antibodies directed at non-phosphorylated epitopes (T49, Tau3R, Tau4R), phosphorylated epitopes (MC6, AT180, CP13), or an abnormal tau conformation (MC1), in wild-type (WT) mice with tau hyperphosphorylation (hypothermic), transgenic mice overexpressing human tau (hTau mice), and tau knockout (TKO) mice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tauopatías / Enfermedad de Alzheimer Límite: Animals / Humans Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tauopatías / Enfermedad de Alzheimer Límite: Animals / Humans Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos